Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Titan Pharmaceuticals, Inc. (TTNP) had Weighted-Average Shares Outstanding (Diluted) of 0.90M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-4.71M |
|
-- |
|
-- |
|
$4.56M |
|
$-4.56M |
|
$-0.15M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.56M |
|
$-4.55M |
|
0.90M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.90M |
$-5.23 |
|
$-5.23 |
|
| Balance Sheet Financials | |
$2.92M |
|
-- |
|
-- |
|
$2.92M |
|
$0.48M |
|
-- |
|
-- |
|
$0.48M |
|
$2.44M |
|
$2.44M |
|
$2.44M |
|
0.91M |
|
| Cash Flow Statement Financials | |
$-3.88M |
|
-- |
|
$-0.06M |
|
$6.77M |
|
$2.83M |
|
$-3.94M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-192.95% |
|
-192.87% |
|
-161.00% |
|
-192.87% |
|
$2.67 |
|
$-4.32 |
|
$-4.32 |
|